Back
Hepion Pharmaceuticals Stock Price Chart
FREE REPORT: "Top 5 Stocks for 2025" from Louis Navellier
Click here to access your free report today.
Sell
17
HEPA
Hepion Pharmaceuticals
Last Price:
$0.28
Seasonality Move:
-14.52%
7 Day Trial
ALL ACCESS PASS
$
7
Get Louis Navellier's "Post-Tariff Recovery Stocks" Report (FREE)
Access your free report today.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HEPA is experiencing selling pressure, which indicates risk of future bearish movement.
Hepion Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.29 | Sell |
| 20-day SMA: | 0.35 | Sell |
| 50-day SMA: | 1.98 | Sell |
| 200-day SMA: | 22.75 | Sell |
| 8-day EMA: | 0.3 | Sell |
| 20-day EMA: | 0.52 | Sell |
| 50-day EMA: | 3.22 | Sell |
| 200-day EMA: | 33.71 | Sell |
Hepion Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.51 | Sell |
| Relative Strength Index (14 RSI): | 21.38 | Sell |
| Chaikin Money Flow: | -19280014 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.29 - 0.45) | Sell |
| Bollinger Bands (100): | (-0.29 - 21.29) | Sell |
Hepion Pharmaceuticals Technical Analysis
| Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Hepion Pharmaceuticals Stock
Is Hepion Pharmaceuticals Stock a Buy?
-
Hepion Pharmaceuticals share price is 0.28 while HEPA 8-day simple moving average is 0.29, which is a Sell signal.
-
The stock price of HEPA is 0.28 while Hepion Pharmaceuticals 20-day SMA is 0.35, which makes it a Sell.
-
Hepion Pharmaceuticals 50-day simple moving average is 1.98 while HEPA share price is 0.28, making it a Sell technically.
-
HEPA stock price is 0.28 and Hepion Pharmaceuticals 200-day simple moving average is 22.75, creating a Sell signal.
HEPA Technical Analysis vs Fundamental Analysis
Sell
17
Hepion Pharmaceuticals (HEPA)
is a Sell
Is Hepion Pharmaceuticals a Buy or a Sell?
-
Hepion Pharmaceuticals stock is rated a SellThe current Hepion Pharmaceuticals [HEPA] share price is $0.28. The Score for HEPA is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
Hepion Pharmaceuticals Stock Info
Market Cap:
3.1M
Price in USD:
0.28
Share Volume:
20.4M
Hepion Pharmaceuticals 52-Week Range
52-Week High:
79.50
52-Week Low:
0.25
Sell
17
Hepion Pharmaceuticals (HEPA)
is a Sell
Hepion Pharmaceuticals Share Price Forecast
-
What is the Hepion Pharmaceuticals stock price today?The Hepion Pharmaceuticals stock price is 0.28 USD today.
-
Will HEPA stock go up or go down?Hepion Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Hepion Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Hepion Pharmaceuticals is overvalued.
Is Hepion Pharmaceuticals Stock a Buy?
-
Hepion Pharmaceuticals share price is 0.28 while HEPA 8-day exponential moving average is 0.30, which is a Sell signal.
-
The stock price of HEPA is 0.28 while Hepion Pharmaceuticals 20-day EMA is 0.52, which makes it a Sell.
-
Hepion Pharmaceuticals 50-day exponential moving average is 3.22 while HEPA share price is 0.28, making it a Sell technically.
-
HEPA stock price is 0.28 and Hepion Pharmaceuticals 200-day simple moving average is 33.71, creating a Sell signal.
Technical Analysis of Hepion Pharmaceuticals
Should I short Hepion Pharmaceuticals stock?
-
HEPA Moving Average Covergence Divergence (MACD) indicator is -0.51, suggesting Hepion Pharmaceuticals is a Sell
-
Hepion Pharmaceuticals Relative Strength Index (RSI) is 21.38, which suggest Hepion Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Hepion Pharmaceuticals is (0.29 - 0.45), which suggest Hepion Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Hepion Pharmaceuticals is (-0.29 - 21.29), which suggest Hepion Pharmaceuticals is a Sell
* Hepion Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.